In the setting of a medical cardiology practice, to what extent is statin-induced muscle intolerance an important cause of poor statin adherence, increased healthcare costs, and increased cardiac event rates?

In the setting of a medical cardiology practice, to what extent is statin-induced muscle intolerance an important cause of poor statin adherence, increased healthcare costs, and increased cardiac event rates?

In the setting of a medical cardiology practice, to what extent is statin-induced muscle intolerance an important cause of poor statin adherence, increased healthcare costs, and increased cardiac event rates?


Created by

CMEducation Resources IQ&A Cardiovascular Intelligence Zone | The Medical Cardiology, Interventional Cardiology, Lipid Medicine, Atherosclerosis and Diabetes Specialist's Perspective

Presenter

Robert Rosenson, MD

Robert Rosenson, MD

Professor of Medicine (Cardiology) Mount Sinai Icahn School of Medicine Director, Cardiometabolics Unit Mount Sinai Heart Institute New York, NY